Corcept Therapeutics total liabilities and share holders equity for the quarter ending September 30, 2024 was $0.784B, a 32.02% increase year-over-year.
Corcept Therapeutics total liabilities and share holders equity for 2023 was $0.622B, a 6.53% increase from 2022.
Corcept Therapeutics total liabilities and share holders equity for 2022 was $0.583B, a 37.68% increase from 2021.
Corcept Therapeutics total liabilities and share holders equity for 2021 was $0.424B, a 25.88% decline from 2020.
Corcept Therapeutics Total Liabilities and Share Holders Equity 2010-2024 | CORT